+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer



Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer



International Journal Of Radiation Oncology Biology Physics. 28(2): 355-362



Purpose: The probability of treatment resistant cells developing in a tumor, such as small cell lung cancer (SCLC) which has a rapid cell cycle time, is a function of the number of tumor cells present and of time. Theoretically, the development of resistance to chemotherapy and radiotherapy should be minimized by using all treatment modalities early in the treatment program. Methods and Materials: The importance of the timing of loco-regional radiotherapy was assessed in a multi-institution randomized study. Three hundred and eight patients with limited small cell lung cancer (LSCLC) were given three cycles of cyclophosphamide, doxorubicin and vincristine alternating with three cycles of etoposide and cisplatin. In addition, patients were randomized to receive locoregional radiotherapy: 40 Gy in 15 fractions in 3 weeks with treatment planning techniques to limit the spinal cord dose to be ltoreq 35 Gy either with the first cycle (early) or with the sixth cycle of chemotherapy (late). Responding patients received prophylactic brain irradiation (25 Gy in 10 fractions in 2 weeks) after completion of locoregional radiotherapy and chemotherapy. Results: 96% of the, 155 eligible patients allocated to the "early" arm and 87% of the 153 allocated to the "late" arm received locoregional radiotherapy; 26 patients did not receive locoregional radiotherapy. The mean field sizes were similar in both arms. The mean radiation doses were significantly less in the "early" arm (p = 0.0319 Wilcoxon rank sum test). Any differences in the frequency of toxicities were minor. All patients have been followed for at least 2 years and the median follow up is 4 years. 64% had a complete response in the "early" arm compared with 56% in the "late" arm (p = 0.137). Survival was measured from the start of chemotherapy. There was a significant improvement in survival in the "early" arm; median survival was 21.2 months compared with 16.0 months in the "late" arm (p = .008 log rank test). Survival at 2, 3, and 4 years was 40%, 32%, and 25%, respectively, for the "early" arm and 33%, 22%, and 15% for the "late" arm. There were 232 (75%) recurrences among those patients whose disease recurred. The proportion who had local recurrence within the radiation field was 41% and 39% for "early" and "late" treatment arms respectively. The proportion of brain metastases in the "late" arm (28%) was significantly higher than in the "early" arm (18%) p = .0425 Fishers' exact test. Conclusion: We conclude that early administration of locoregional radiotherapy in a combined modality treatment is superior to late consolidative locoregional radiotherapy in limited small cell lung cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 009165726

Download citation: RISBibTeXText

PMID: 8276650

DOI: 10.1016/0360-3016(94)90058-2


Related references

Loco regional failure rate in relation with radiation dose in combined modality approach of multiagent chemotherapy and radiotherapy for limited stage small cell lung carcinoma. International Journal of Radiation Oncology, Biology, Physics 13(SUPPL 1): 188-189, 1987

Reassessment of loco-regional failure rate in relation with radiation dose in combined modality approach of multidrug chemotherapy and radiotherapy for limited-stage small-cell lung carcinoma. Antibiotics and ChemoTherapy 41: 70-76, 1988

Reassessment of loco-regional failure rate in relation with radiation dose in combined modality approach of multidrug chemotherapy and radiotherapy for limited stage small-cell lung carcinoma. Lung Cancer 5(1): 22-23, 1989

Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival. Journal of Medical Imaging and Radiation Oncology 54(5): 483-489, 2011

Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncologica 53(3): 336-341, 2014

Radiotherapy for non-small-cell lung cancer: Relationship between loco-regional failure and irradiated volume. Journal of Clinical Oncology 23(16_suppl): 7263-7263, 2016

Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy. Acta Oncologica 54(9): 1574-1581, 2016

Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation. RadioTherapy and Oncology 125(1): 130-135, 2017

Limited-stage small cell lung cancer Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. International Journal of Radiation Oncology Biology Physics 27(SUPPL 1): 188-189, 1993

Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. Journal of Clinical Oncology 12(3): 496-502, 1994

Patterns of failure in combined chemotherapy and radiotherapy for limited small cell lung cancer: Southeastern Cancer Study Group experience. Nci Monographs 6): 265-270, 1988

Patterns of Failure for Limited-Stage Small Cell Lung Cancer Following Definitive Radiation Therapy in the Modern Era. International Journal of Radiation Oncology*biology*physics 84(3): S595-S596, 2012

Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. RadioTherapy and Oncology 101(2): 245-249, 2012

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update. International Journal of Radiation Oncology, Biology, Physics 17(2): 307-310, 1989

Research on Postoperative Radiotherapy for Non-small Cell Lung Cancer of Stage IIIA (N2) according to the Failure Patterns after Pulmonary Resection.. Zhongguo Fei Ai Za Zhi 12(10): 1095-1100, 2010